Onyx Biotec Ratios

Onyx Biotec Ltd Ratios

The Onyx Biotec Ltd Ratios page provides a complete fundamental analysis of Onyx Biotec Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Onyx Biotec Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Onyx Biotec Ltd (NSE: ONYX, BSE: 93585) is currently trading at ₹33, with a market capitalization of ₹598.36M. As a major player in the Health technology sector and Pharmaceuticals: major industry, Onyx Biotec Ltd remains a key stock for fundamental analysis using Onyx Biotec Ltd Ratios.

Onyx Biotec Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Onyx Biotec Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Onyx Biotec Ltd Ratios.

Historically, the Onyx Biotec Ltd P/E ratio has shown strong fluctuations:

The decline in Onyx Biotec Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Onyx Biotec Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

Onyx Biotec Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Onyx Biotec Ltd P/S ratio currently stands at 0, an important part of Onyx Biotec Ltd Ratios for revenue valuation.

Historical P/S ratio:

A stable or declining Onyx Biotec Ltd P/S ratio indicates cautious market sentiment.

Onyx Biotec Ltd Price to Cash Flow Ratio (P/CF)

The Onyx Biotec Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Onyx Biotec Ltd Price to Cash Flow Ratio:

The declining Onyx Biotec Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Onyx Biotec Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Onyx Biotec Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

Onyx Biotec Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Onyx Biotec Ltd EV/EBITDA ratio is currently 0, a key metric in Onyx Biotec Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

Stable Onyx Biotec Ltd EV/EBITDA indicates balanced valuation.

Onyx Biotec Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Onyx Biotec Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

Onyx Biotec Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Onyx Biotec Ltd ROE currently stands at 0%, showing profitability and capital efficiency.

Historical ROE:

Declining ROE indicates pressure on profitability.

Onyx Biotec Ltd Ratios Analysis Summary

The Onyx Biotec Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Onyx Biotec Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Onyx Biotec Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.